Should routine screening for coeliac disease be considered before starting interferon/ribavirin treatment in patients affected by chronic hepatitis C?
Casella
Giovanni
G
Bardella
Maria Teresa
MT
Perego
Daniele
D
Baldini
Vittorio
V
D000998:Antiviral Agents / Q000627:therapeutic use*; D002446:Celiac Disease / Q000175:diagnosis*; D019698:Hepatitis C, Chronic / Q000188:drug therapy*; D006801:Humans; D007372:Interferons / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D012254:Ribavirin / Q000627:therapeutic use*
D000998:Antiviral Agents; D012254:Ribavirin; D007372:Interferons